15 Best Penny Stocks to Buy Now
Many novice investors are bullish on penny stocks with growth potential for capital appreciation. All iconic stocks were once penny stocks.
Celsion Corp (CLSN)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 39,737 | $201 | 0% | |
| 2. | Citadel Investment Group Ken Griffin | 32,900 | $166 | 0% | |
| 3. | Renaissance Technologies Jim Simons | 26,555 | $134 | 0% | |
| 4. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.53 | 4,000 | Officer, Director | 16,513 | 2022-04-12 | Filing | |
| $4.05 | 5,000 | Director | 11,766 | 2022-04-08 | Filing | |
| $4.69 | 2,000 | Director | 6,766 | 2022-03-02 | Filing | |
| $0.88 | 20,000 | Director | 71,491 | 2021-10-07 | Filing | |
| $1.07 | 5,000 | Director | 5,357 | 2021-05-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.08 | 5,556 | Large Shareholder | 2,421,867 | 2015-12-03 | Filing | |
| $2.15 | 15,000 | Large Shareholder | 2,427,423 | 2015-12-01 | Filing | |
| $2.15 | 20,000 | Large Shareholder | 2,442,423 | 2015-11-30 | Filing | |
| $2.11 | 10,000 | Large Shareholder | 2,462,423 | 2015-09-08 | Filing | |
| $2.19 | 10,000 | Large Shareholder | 2,472,423 | 2015-08-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 234,953 | $1,189 | 0% | |
| 2. | 74,918 | $379 | 0% | |
| 3. | 50,457 | $255 | 0% | |
| 4. | 43,300 | $219 | 0% | |
| 5. | 35,520 | $180 | 0% |
News See All
Do Hedge Funds Love Celsion Corporation (CLSN)?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Hedge Funds Have Never Been This Bullish On Celsion Corporation (CLSN)
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
13G Filing: Sabby Capital and Celsion Corp (CLSN)
Sabby Healthcare Master Fund, Ltd | 0 | 214,321 | 0 | 214,321 | 214,321 | 1.33 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 15117n305 1.
13G Filing: Intracoastal Capital, Llc and Celsion Corp (NASDAQ:CLSN)
You can access the original SEC filing by clicking here.
Why Are These Healthcare Stocks Making Big Moves Today?
The week’s trading is underway and several biotech stocks are hot out of the gates, making big early morning gains.
Celsion Corporation (CLSN), Idenix Pharmaceuticals Inc (IDIX), GTx, Inc. (GTXI): Three Biotech Stocks That May Go to Zero
The biotech industry is a marvel among traders and investors because it can double your investment, or halve it, based on a single clinical study.
Celgene Corporation (CELG) Soars in 2013; What Does the Future Hold?
The biotechnology industry is one of the favorite industries for investing in up-and-coming companies. A lot of them offer promise, but few end up making it to the finish line.
Hedge Funds Are Selling Affymax, Inc. (AFFY) – Northwest Biotherapeutics, Inc (NWBO), Celsion Corporation (CLSN)
In today’s marketplace, there are many metrics investors can use to watch Mr. Market. A couple of the most under-the-radar are hedge fund and insider trading interest.
3 Events Biotech Investors Need to Watch in 2013: Vical Incorporated (VICL) and More
It's make-or-break time in 2013. That's the situation for several biotech companies with critical phase 3 trials under way.
Billionaire Hedge Funds
